Transplant Infectious Disease · 2011 · 19 citations · 10 references
PharmacyHematologyInfectious DiseasesStem Cell TransplantationTransplant PharmacotherapyVirologyAntiviral TherapyHematopoietic Stem Cell Transplant PharmacotherapyTransplant Infectious ComplicationsTreatment DurationViral HepatitisViral Hepatitis TreatmentCombination Antiviral RegimensCombination Antiviral TherapyHepatitis B Virus ProphylaxisHepatitis B Virus ReactivationPrevention Of Hepatitis ReactivationProphylaxis Against Hepatitis B ReactivationTenofovir TherapyViral Hepatitis Reactivation
L. Milazzo, M. Corbellino, A. Foschi, V. Micheli, A. Dodero, A. Mazzocchi, V. Montefusco, G. Zehender, S. Antinori. Late onset of hepatitis B virus reactivation following hematopoietic stem cell transplantation: successful treatment with combined entecavir plus tenofovir therapy. Transpl Infect Dis 2011. All rights reserved Abstract: Prophylaxis with lamivudine (LAM) is recommended for hepatitis B core antibody‐positive allogenic hematopoietic stem cell transplant (HSCT) recipients, but the optimal timing for the institution and duration of the prophylaxis is still unknown. Furthermore, considering the high rate of mortality associated with hepatitis B virus reactivation (HBV‐R), the most potent and long‐term effective antiviral regimen should be considered. We report here a case of late onset of HBV‐R after a long‐term prophylaxis with LAM in a patient who underwent HSCT for non‐Hodgkin lymphoma and who was successfully treated with a combination antiviral regimen including entecavir and tenofovir disoproxil fumarate.
10
REVERSE SEROCONVERSION OF HEPATITIS B AFTER ALLOGENEIC BONE MARROW TRANSPLANTATION
Nathalie Dh din, Catherine Douvin, Mathieu Kuentz et al. · Transplantation · 1998 · 175 citations
Medicine, Hematology, Immunology +15
Masahiro Onozawa, Satoshi Hashino, Koh Izumiyama et al. · Transplantation · 2005 · 158 citations